The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. (Q48176997)

9 February 2018

title

The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. (English)

1 reference

9 February 2018

author

Anja Bosserhoff

12

1 reference

9 February 2018

Manfred Schartl

13

1 reference

9 February 2018

author name string

K Maurus

1

1 reference

9 February 2018

A Hufnagel

2

1 reference

9 February 2018

F Geiger

3

1 reference

9 February 2018

S Graf

4

1 reference

9 February 2018

C Berking

5

1 reference

9 February 2018

A Heinemann

6

1 reference

9 February 2018

A Paschen

7

1 reference

9 February 2018

S Kneitz

8

1 reference

9 February 2018

C Stigloher

9

1 reference

9 February 2018

E Geissinger

10

1 reference

9 February 2018

C Otto

11

1 reference

9 February 2018

S Meierjohann

14

1 reference

9 February 2018

language of work or name

English

0 references

publication date

8 May 2017

1 reference

9 February 2018

published in

Oncogene

1 reference

9 February 2018

volume

36

1 reference

9 February 2018

issue

36

1 reference

9 February 2018

page(s)

5110-5121

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/onc.2017.135

exact match

0 references

cites work

Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Fortuitous convergences: the beginnings of JUN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Isolation and characterization of fra-2, an additional member of the fos gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Activation of the Wnt pathway interferes with serum response element-driven transcription of immediate early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Proliferative activation of quiescent Rat-1A cells by delta FosB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

c-fos is required for malignant progression of skin tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

The FOS transcription factor family differentially controls trophoblast migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

The Genetic Evolution of Melanoma from Precursor Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Comparative genome hybridization analysis of laser-capture microdissected in situ melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Human neural crest cells display molecular and phenotypic hallmarks of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Nucleolar marker for living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

A liaison between mTOR signaling, ribosome biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.135

31 March 2020

Identifiers

DOI

10.1038/ONC.2017.135

1 reference

9 February 2018

release_ozu25ouvtbat7bzgl6xuyoopwi

Fatcat ID

0 references

PubMed ID

28481878

1 reference

9 February 2018